Imciromab

Imciromab (trade name Myoscint) is a mouse monoclonal antibody which was used for cardiac imaging. It was withdrawn in 1993.

Also known as:

  • Myoscint

Facts from the Community

From the BioVenturist base

Brand Names:

  • Myoscint

Stage of development:

Target/Biomolecule of Interest:

top ↑

We can tell you that Imciromab is a…

If you know more about Imciromab, you can add more facts here »

You can help improve this topic by adding more facts here

Edit this topic
Edit and Show details

Add or delete facts, download data in JSON or RDF formats, and explore topic metadata.

Freebase Logo
What is Freebase?

Freebase is a huge collection of facts, built by people like you. Freebase connects facts in ways other sites can't, giving you new ways to explore millions of subjects.
You can help improve it!

Freebase Attribution

Freebase data is free for use under the CC-BY license.

The original description for Imciromab was automatically generated from Wikipedia.org licensed under the GNU Free Documentation License.
[1]
Learn more about Freebase licensing and attribution